"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","42/71","499/2914",7.41388477572819e-16,4.19635312884717e-13,2.71999575818953e-13,"CASP1/CREBBP/CTNNB1/E2F1/MAX/NR4A1/SMAD3/SMAD4/TP53/MAPK1/MAPK14/MAPK3/PRKACA/CHEK1/HDAC1/SKP2/SP1/CSNK2A1/EP300/GSK3B/SMAD2/STAT1/NOTCH1/SIRT1/SMAD7/AR/CAV1/EGFR/ESR1/NR3C1/PPP2CA/FOXO4/MYBL2/TBP/NR2F1/MAF/JUNB/RUNX2/FOXO3/TFDP1/GATA3/POU2F1",42
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","41/71","481/2914",1.40817219088831e-15,4.19635312884717e-13,2.71999575818953e-13,"CASP1/CREBBP/CTNNB1/E2F1/MAX/NR4A1/SMAD3/SMAD4/TP53/MAPK1/MAPK14/MAPK3/PRKACA/CHEK1/HDAC1/SKP2/SP1/CSNK2A1/EP300/GSK3B/SMAD2/STAT1/NOTCH1/SIRT1/SMAD7/AR/CAV1/EGFR/ESR1/NR3C1/PPP2CA/FOXO4/MYBL2/TBP/NR2F1/MAF/JUNB/RUNX2/FOXO3/TFDP1/GATA3",41
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","11/71","49/2914",1.1376888352119e-08,2.26020848595431e-06,1.46502386850094e-06,"CREBBP/SMAD3/SMAD4/HDAC1/EP300/SMAD2/SIRT1/CAV1/NR3C1/FOXO4/FOXO3",11
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","8/71","24/2914",4.48724864700464e-08,6.68600048403692e-06,4.3337375090808e-06,"SMAD3/SMAD4/HDAC1/SP1/SMAD2/SMAD7/JUNB/TFDP1",8
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","7/71","19/2914",1.50977260067885e-07,1.36766314165056e-05,8.86493064263081e-06,"SMAD3/SMAD4/HDAC1/SMAD2/NR3C1/FOXO4/FOXO3",7
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","11/71","62/2914",1.54477875334662e-07,1.36766314165056e-05,8.86493064263081e-06,"SMAD4/MAPK1/MAPK3/SKP2/GSK3B/STAT1/AR/ESR1/NR3C1/MAF/RUNX2",11
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","14/71","108/2914",1.63592448953603e-07,1.36766314165056e-05,8.86493064263081e-06,"CREBBP/MAPK1/MAPK3/HDAC1/SP1/EP300/CAV1/EGFR/ESR1/TBP/FOXA1/FOXO3/GATA3/POU2F1",14
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","11/71","63/2914",1.83578945187995e-07,1.36766314165056e-05,8.86493064263081e-06,"PPP1CC/PPP1R15A/SMAD3/SMAD4/HDAC1/SP1/SMAD2/PPP1CA/SMAD7/JUNB/TFDP1",11
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","6/71","14/2914",4.35515351243865e-07,2.88407943712604e-05,1.86940507492981e-05,"SMAD3/SMAD4/SMAD2/CAV1/FOXO4/FOXO3",6
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","15/71","136/2914",4.89762557080246e-07,2.91898484019827e-05,1.89203008893106e-05,"CREBBP/MAPK1/MAPK3/HDAC1/PDK1/SP1/EP300/CAV1/EGFR/ESR1/TBP/FOXA1/FOXO3/GATA3/POU2F1",15
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","21/71","268/2914",6.38615917293719e-07,3.37527896524363e-05,2.18779120495304e-05,"CREBBP/CTNNB1/NR4A1/SMAD3/SMAD4/STAT3/MAPK1/MAPK3/FGFR1/HDAC1/EP300/GSK3B/SMAD2/STAT1/NOTCH1/EGFR/ESR1/LCK/PPP2CA/FOXO4/FOXO3",21
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","7/71","23/2914",6.79586368841e-07,3.37527896524363e-05,2.18779120495304e-05,"E2F1/TP53/MAPK1/MAPK3/SP1/ETS2/TFDP1",7
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","17/71","187/2914",1.23997678799559e-06,5.68481665881055e-05,3.684789321412e-05,"CREBBP/E2F1/STAT3/TP53/MAPK1/MAPK14/MAPK3/RELA/SP1/EP300/GSK3B/SIRT1/AR/NR3C1/ETS2/HIF1A/TFDP1",17
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","17/71","189/2914",1.44333152099812e-06,5.80655636740926e-05,3.76369866979724e-05,"CREBBP/E2F1/STAT3/TP53/MAPK1/MAPK14/MAPK3/RELA/SP1/EP300/GSK3B/SIRT1/AR/NR3C1/ETS2/HIF1A/TFDP1",17
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","8/71","36/2914",1.46138163609294e-06,5.80655636740926e-05,3.76369866979724e-05,"SMAD3/SMAD4/HDAC1/SP1/SMAD2/SMAD7/JUNB/TFDP1",8
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","9/71","49/2914",1.70531406834073e-06,5.9924367300211e-05,3.88418276212954e-05,"CREBBP/HDAC1/SP1/EP300/ESR1/TBP/FOXA1/GATA3/POU2F1",9
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","5/71","10/2914",1.70925208742213e-06,5.9924367300211e-05,3.88418276212954e-05,"CREBBP/EP300/SIRT1/FOXO4/FOXO3",5
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","25/71","397/2914",2.62953610394312e-06,8.70668621083387e-05,5.64350731080189e-05,"CREBBP/CTNNB1/E2F1/PAX6/SMAD3/SMAD4/STAT3/MAPK1/MAPK14/MAPK3/PRKACA/FGFR1/RELA/CSNK2A1/EP300/GSK3B/SMAD2/NOTCH1/EGFR/NR2F2/SREBF2/MEF2A/CEBPA/FOXO3/TFDP1",25
"R-HSA-400253","R-HSA-400253","Circadian Clock","9/71","52/2914",2.88053485966753e-06,8.87479740760085e-05,5.7524737700274e-05,"CREBBP/PPP1CC/EP300/PER2/PPP1CA/SIRT1/NR3C1/BHLHE40/HIF1A",9
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","7/71","28/2914",2.97811993543653e-06,8.87479740760085e-05,5.7524737700274e-05,"PPP1CC/PPP1R15A/SMAD3/SMAD4/SMAD2/PPP1CA/SMAD7",7
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","11/71","86/2914",4.6752898315851e-06,0.000132689178077367,8.60065848717659e-05,"PPP1CC/PPP1R15A/SMAD3/SMAD4/HDAC1/SP1/SMAD2/PPP1CA/SMAD7/JUNB/TFDP1",11
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","12/71","104/2914",4.98335378906578e-06,0.000135003584467418,8.75067387840737e-05,"CREBBP/E2F1/SMAD3/TP53/HDAC1/EP300/STAT1/NOTCH1/EGFR/IKZF1/HIF1A/TFDP1",12
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","6/71","22/2914",9.27136217990521e-06,0.000240249211270587,0.000155724939131589,"PPP1CC/PPP1R15A/SMAD3/SMAD2/PPP1CA/SMAD7",6
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","6/71","23/2914",1.23037536426338e-05,0.000305543215458738,0.000198047262580991,"CREBBP/E2F1/TP53/EP300/NOTCH1/TFDP1",6
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","6/71","24/2914",1.60913584755334e-05,0.000360930276140898,0.00023394809492001,"MAPK1/MAPK14/MAPK3/PPP2CA/ATF1/MEF2A",6
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","6/71","24/2914",1.60913584755334e-05,0.000360930276140898,0.00023394809492001,"SMAD4/MAPK1/MAPK3/AR/MAF/RUNX2",6
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","10/71","80/2914",1.63508682144366e-05,0.000360930276140898,0.00023394809492001,"SMAD3/SMAD4/TP53/SKP2/SMAD2/SMAD7/AR/FOXO4/HIF1A/GATA3",10
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","21/71","332/2914",2.11275920842741e-05,0.000449715888650977,0.000291497229132654,"CASP1/SMAD3/STAT3/TP53/MAPK1/MAPK14/MAPK3/PRKACA/RELA/SYK/STAT1/CASP3/LCK/PPP2CA/ATF1/JUNB/MEF2A/HIF1A/FOXO3/GATA3/POU2F1",21
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","6/71","26/2914",2.6482487706465e-05,0.000544260781829419,0.000352779418812075,"SKP2/GSK3B/STAT1/ESR1/NR3C1/RUNX2",6
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","8/71","53/2914",3.07316962138118e-05,0.000599851858192824,0.00038881249020976,"CREBBP/CTNNB1/SMAD3/SMAD4/TP53/EP300/NOTCH1/FOXO3",8
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","12/71","124/2914",3.12003483288214e-05,0.000599851858192824,0.00038881249020976,"SMAD3/SMAD4/TP53/SKP2/EP300/SMAD2/SMAD7/AR/ESR1/FOXO4/HIF1A/GATA3",12
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","15/71","191/2914",3.57151036901596e-05,0.000665193806229223,0.000431165889943703,"E2F1/MAX/PPP1CC/TP53/MAPK1/MAPK3/PRKACA/HDAC1/SKP2/CSNK2A1/EP300/GSK3B/PPP2CA/MYBL2/TFDP1",15
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","14/71","172/2914",4.56959690757622e-05,0.000825296896034978,0.00053494164755358,"NR4A1/TP53/MAPK1/MAPK3/FGFR1/HDAC1/CSNK2A1/GSK3B/EGFR/ESR1/LCK/PPP2CA/FOXO4/FOXO3",14
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","5/71","18/2914",4.99022135204494e-05,0.000874756448770231,0.000567000382724611,"CREBBP/EP300/STAT1/NOTCH1/IKZF1",5
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","6/71","29/2914",5.15670796168529e-05,0.000878113698618409,0.000569176487801053,"CREBBP/E2F1/TP53/EP300/NOTCH1/TFDP1",6
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","4/71","10/2914",6.08818284231531e-05,0.00096593486959719,0.000626100489477514,"E2F1/HDAC1/MYBL2/TFDP1",4
"R-HSA-1643685","R-HSA-1643685","Disease","24/71","443/2914",6.25160781885119e-05,0.00096593486959719,0.000626100489477514,"CREBBP/CTNNB1/NR4A1/SMAD3/SMAD4/STAT3/MAPK1/MAPK3/PRKACA/FGFR1/HDAC1/RELA/EP300/GSK3B/SMAD2/STAT1/NOTCH1/EGFR/ESR1/LCK/PPP2CA/FOXO4/TBP/FOXO3",24
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","6/71","30/2914",6.32275515739702e-05,0.00096593486959719,0.000626100489477514,"MAPK1/MAPK14/MAPK3/PPP2CA/ATF1/MEF2A",6
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","15/71","201/2914",6.53043381108068e-05,0.00096593486959719,0.000626100489477514,"NR4A1/TP53/MAPK1/MAPK3/PRKACA/FGFR1/HDAC1/CSNK2A1/GSK3B/EGFR/ESR1/LCK/PPP2CA/FOXO4/FOXO3",15
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","5/71","19/2914",6.6448539687055e-05,0.00096593486959719,0.000626100489477514,"E2F1/MAX/HDAC1/MYBL2/TFDP1",5
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","5/71","19/2914",6.6448539687055e-05,0.00096593486959719,0.000626100489477514,"MAPK1/MAPK3/AR/MAF/RUNX2",5
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","5/71","20/2914",8.69294050360756e-05,0.00123356965241669,0.000799576231785457,"MAPK1/MAPK3/FGFR1/CSNK2A1/EGFR",5
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","4/71","11/2914",9.39146106082117e-05,0.00130170018424405,0.000843737138144767,"E2F1/MAX/HDAC1/TFDP1",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","10/71","99/2914",0.000106855614052585,0.00144740786307593,0.000938182065964087,"E2F1/STAT3/TP53/MAPK1/MAPK14/MAPK3/RELA/SP1/ETS2/TFDP1",10
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","5/71","21/2914",0.000111946633442705,0.0014826709673745,0.000961038935051997,"MAPK1/MAPK14/MAPK3/PPP2CA/MEF2A",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","7/71","49/2914",0.000143658663173426,0.00186131659242091,0.00120646977996905,"E2F1/STAT3/TP53/MAPK1/MAPK3/CASP3/TFDP1",7
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","4/71","13/2914",0.000196082896162393,0.00248649800239971,0.00161170040070769,"CREBBP/EP300/FOXO4/FOXO3",4
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","6/71","37/2914",0.000216307439964001,0.0025965516877999,0.00168303509258665,"HDAC1/EP300/GSK3B/SIRT1/TDG/TBP",6
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","6/71","37/2914",0.000216307439964001,0.0025965516877999,0.00168303509258665,"CREBBP/EP300/STAT1/NOTCH1/EGFR/IKZF1",6
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","16/71","249/2914",0.000217831517432878,0.0025965516877999,0.00168303509258665,"E2F1/MAX/PPP1CC/TP53/MAPK1/MAPK3/PRKACA/CHEK1/HDAC1/SKP2/CSNK2A1/EP300/GSK3B/PPP2CA/MYBL2/TFDP1",16
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","5/71","25/2914",0.000270902644487204,0.00316584266890929,0.00205203860736437,"CREBBP/EP300/EGFR/ESR1/MYBL2",5
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","6/71","40/2914",0.000337089825407956,0.00386356799890657,0.00250429080819271,"CREBBP/RELA/EP300/NR2F2/SREBF2/CEBPA",6
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","4/71","15/2914",0.00036074311575222,0.00398153512941339,0.00258075484368547,"SMAD3/SMAD4/SMAD2/FOXO3",4
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","4/71","15/2914",0.00036074311575222,0.00398153512941339,0.00258075484368547,"HDAC1/EP300/GSK3B/TBP",4
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","5/71","27/2914",0.000396302398449478,0.00429447689956161,0.00278359770776954,"E2F1/STAT3/EP300/CEBPA/TFDP1",5
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","6/71","44/2914",0.000573997804840682,0.00610897663723298,0.00395972169880696,"E2F1/TP53/MAPK1/MAPK14/MAPK3/TFDP1",6
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","4/71","17/2914",0.000606166100832934,0.00633815782625313,0.00410827255781508,"CREBBP/SMAD3/EP300/NOTCH1",4
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","4/71","18/2914",0.000765098640065074,0.0078620480944618,0.00509602905451692,"E2F1/MAX/CHEK1/TFDP1",4
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","4/71","19/2914",0.000951405333499212,0.00953539245323384,0.00618065883139672,"CREBBP/PRKACA/RELA/EP300",4
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","9/71","107/2914",0.000959938837573877,0.00953539245323384,0.00618065883139672,"CREBBP/TP53/HDAC1/RELA/EP300/AR/ESR1/NR3C1/TDG",9
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","6/71","49/2914",0.00103283965800296,0.0100913514126191,0.00654102078493677,"CREBBP/MAPK1/MAPK3/EP300/GSK3B/SIRT1",6
"R-HSA-2990846","R-HSA-2990846","SUMOylation","9/71","109/2914",0.00109771981448903,0.0105522743457333,0.00683978220572962,"CREBBP/TP53/HDAC1/RELA/EP300/AR/ESR1/NR3C1/TDG",9
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","4/71","20/2914",0.00116752431561499,0.010969040956862,0.00710992234399212,"SMAD3/SMAD4/HDAC1/SMAD2",4
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","5/71","34/2914",0.00119628802381884,0.010969040956862,0.00710992234399212,"CREBBP/CTNNB1/RELA/EP300/PRKDC",5
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","5/71","34/2914",0.00119628802381884,0.010969040956862,0.00710992234399212,"DUSP2/MAPK1/MAPK3/DUSP5/PPP2CA",5
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","7/71","70/2914",0.00133381963788358,0.0120447955178578,0.00780720585491664,"STAT3/MAPK1/MAPK14/MAPK3/PPP2CA/ATF1/MEF2A",7
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","3/71","10/2914",0.00147157593820861,0.0127110037561207,0.00823902928028312,"E2F1/PPP2CA/TFDP1",3
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/71","10/2914",0.00147157593820861,0.0127110037561207,0.00823902928028312,"MAPK1/MAPK14/MAPK3",3
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","3/71","10/2914",0.00147157593820861,0.0127110037561207,0.00823902928028312,"EP300/GSK3B/TBP",3
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","4/71","22/2914",0.00169895115546343,0.0144653555522315,0.00937616652714405,"CREBBP/CTNNB1/HDAC1/EP300",4
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","8/71","94/2914",0.00173569727685582,0.0145700785493812,0.00944404596895603,"STAT3/TP53/STAT1/JUNB/HIF1A/FOXO3/GATA3/POU2F1",8
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/71","95/2914",0.0018587345439819,0.0153861915029613,0.00997303476083857,"TP53/MAPK14/CHEK1/HDAC1/CSNK2A1/EP300/PPP2CA/TBP",8
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/71","11/2914",0.00198819893605875,0.0160130617012299,0.0103793600218145,"E2F1/PPP2CA/TFDP1",3
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","3/71","11/2914",0.00198819893605875,0.0160130617012299,0.0103793600218145,"SMAD4/STAT3/SMAD2",3
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","4/71","23/2914",0.00201910669915803,0.0160451679026425,0.0104001706468912,"DUSP2/MAPK1/MAPK3/DUSP5",4
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","9/71","119/2914",0.00204843103009532,0.0160640117623265,0.0104123848759693,"CREBBP/PPP1CC/PRKACA/SP1/CSNK2A1/EP300/PPP1CA/CAV1/SREBF2",9
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","12/71","194/2914",0.00210641114588652,0.0162412165310312,0.0105272456144268,"CASP1/CREBBP/E2F1/TP53/MAPK14/CHEK1/HDAC1/CSNK2A1/EP300/PPP2CA/TBP/TFDP1",12
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","8/71","97/2914",0.00212552833795375,0.0162412165310312,0.0105272456144268,"NR4A1/FGFR1/GSK3B/EGFR/ESR1/LCK/FOXO4/FOXO3",8
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","7/71","77/2914",0.00233631187331853,0.0170602474838908,0.0110581257975767,"E2F1/MAX/HDAC1/SKP2/PPP2CA/MYBL2/TFDP1",7
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","4/71","24/2914",0.00237875289206797,0.0170602474838908,0.0110581257975767,"CREBBP/PAX6/EP300/NOTCH1",4
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/71","24/2914",0.00237875289206797,0.0170602474838908,0.0110581257975767,"NR4A1/GSK3B/FOXO4/FOXO3",4
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","4/71","24/2914",0.00237875289206797,0.0170602474838908,0.0110581257975767,"MAPK1/MAPK3/EGFR/FOXO3",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/71","24/2914",0.00237875289206797,0.0170602474838908,0.0110581257975767,"STAT3/MAPK1/MAPK3/STAT1",4
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","7/71","78/2914",0.00251741883744096,0.0170602474838908,0.0110581257975767,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","7/71","78/2914",0.00251741883744096,0.0170602474838908,0.0110581257975767,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","7/71","78/2914",0.00251741883744096,0.0170602474838908,0.0110581257975767,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","5/71","40/2914",0.00252558101516067,0.0170602474838908,0.0110581257975767,"CREBBP/HDAC1/EP300/NOTCH1/HIF1A",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","3/71","12/2914",0.00260483644468802,0.0170602474838908,0.0110581257975767,"MAPK1/MAPK3/CASP3",3
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/71","12/2914",0.00260483644468802,0.0170602474838908,0.0110581257975767,"SMAD3/SMAD4/SMAD2",3
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/71","12/2914",0.00260483644468802,0.0170602474838908,0.0110581257975767,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","3/71","12/2914",0.00260483644468802,0.0170602474838908,0.0110581257975767,"CREBBP/EP300/NOTCH1",3
"R-HSA-109581","R-HSA-109581","Apoptosis","8/71","101/2914",0.00274952963310923,0.0178121702318815,0.0115455077271291,"CTNNB1/E2F1/STAT3/TP53/MAPK1/MAPK3/CASP3/TFDP1",8
"R-HSA-450294","R-HSA-450294","MAP kinase activation","6/71","60/2914",0.00299376817398719,0.0189817641669826,0.0123036161237771,"MAPK1/MAPK14/MAPK3/PPP2CA/ATF1/MEF2A",6
"R-HSA-69206","R-HSA-69206","G1/S Transition","6/71","60/2914",0.00299376817398719,0.0189817641669826,0.0123036161237771,"E2F1/MAX/HDAC1/SKP2/PPP2CA/TFDP1",6
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","8/71","103/2914",0.00311120665446532,0.0195187280638035,0.0126516658414268,"CTNNB1/E2F1/STAT3/TP53/MAPK1/MAPK3/CASP3/TFDP1",8
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","3/71","13/2914",0.00332746250924571,0.0204450273763963,0.0132520753216839,"SP1/TBP/POU2F1",3
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","3/71","13/2914",0.00332746250924571,0.0204450273763963,0.0132520753216839,"CREBBP/EP300/NOTCH1",3
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","7/71","83/2914",0.00359125080985045,0.0218406681905191,0.014156702977606,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","6/71","63/2914",0.00383601938297581,0.0222386844175802,0.0144146894758953,"MAPK1/MAPK3/CAV1/EGFR/ESR1/FOXO3",6
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","7/71","84/2914",0.00384263619823099,0.0222386844175802,0.0144146894758953,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","7/71","84/2914",0.00384263619823099,0.0222386844175802,0.0144146894758953,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","6/71","64/2914",0.00415252314674595,0.0222386844175802,0.0144146894758953,"MAPK1/MAPK14/MAPK3/PPP2CA/ATF1/MEF2A",6
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"CREBBP/SP1/SREBF2",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","3/71","14/2914",0.00416145691028595,0.0222386844175802,0.0144146894758953,"TP53/HDAC1/EP300",3
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","8/71","108/2914",0.00417908163551843,0.0222386844175802,0.0144146894758953,"CREBBP/CTNNB1/HDAC1/CSNK2A1/EP300/GSK3B/CAV1/PPP2CA",8
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","7/71","86/2914",0.00438549253399658,0.0225323581919134,0.0146050431939813,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","7/71","86/2914",0.00438549253399658,0.0225323581919134,0.0146050431939813,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","7/71","86/2914",0.00438549253399658,0.0225323581919134,0.0146050431939813,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","7/71","86/2914",0.00438549253399658,0.0225323581919134,0.0146050431939813,"CREBBP/HDAC1/CSNK2A1/EP300/ESR1/RUNX2/GATA3",7
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","7/71","87/2914",0.00467784824034864,0.0233346872916274,0.0151250975556822,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","7/71","87/2914",0.00467784824034864,0.0233346872916274,0.0151250975556822,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","7/71","87/2914",0.00467784824034864,0.0233346872916274,0.0151250975556822,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","5/71","46/2914",0.0046982591862337,0.0233346872916274,0.0151250975556822,"NR4A1/AR/ESR1/NR3C1/NR2F1",5
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","18/71","393/2914",0.00483689998661527,0.0238247305125843,0.0154427341895416,"CREBBP/SMAD3/SMAD4/TP53/HDAC1/RELA/SKP2/EP300/SMAD2/SMAD7/AR/ESR1/NR3C1/PRKDC/TDG/FOXO4/HIF1A/GATA3",18
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/71","15/2914",0.00511163535891937,0.0245688280154512,0.0159250439450205,"TP53/EP300/TFDP1",3
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","3/71","15/2914",0.00511163535891937,0.0245688280154512,0.0159250439450205,"E2F1/HDAC1/TFDP1",3
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","3/71","15/2914",0.00511163535891937,0.0245688280154512,0.0159250439450205,"CASP1/SMAD3/STAT3",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","7/71","89/2914",0.00530665124634922,0.0253021131425931,0.0164003453255593,"STAT3/MAPK1/MAPK14/MAPK3/PPP2CA/ATF1/MEF2A",7
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","4/71","30/2914",0.00549493218489725,0.0255857779859278,0.0165842114461948,"CTNNB1/GSK3B/CAV1/PPP2CA",4
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","4/71","30/2914",0.00549493218489725,0.0255857779859278,0.0165842114461948,"MAPK1/MAPK3/FGFR1/PPP2CA",4
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/71","30/2914",0.00549493218489725,0.0255857779859278,0.0165842114461948,"E2F1/TP53/EP300/TFDP1",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/71","68/2914",0.00561520462615016,0.0256780528006277,0.0166440222144655,"E2F1/TP53/PRKACA/EP300/PPP2CA/MYBL2",6
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","7/71","90/2914",0.00564400153839299,0.0256780528006277,0.0166440222144655,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","7/71","90/2914",0.00564400153839299,0.0256780528006277,0.0166440222144655,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","3/71","16/2914",0.00618227849371967,0.0274972983750517,0.0178232223660261,"MAPK1/MAPK3/CASP3",3
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","3/71","16/2914",0.00618227849371967,0.0274972983750517,0.0178232223660261,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/71","16/2914",0.00618227849371967,0.0274972983750517,0.0178232223660261,"MAPK1/MAPK14/MAPK3",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","7/71","92/2914",0.00636687389885925,0.0281085692127416,0.0182194364201274,"MAPK1/MAPK3/FGFR1/EGFR/ESR1/LCK/PPP2CA",7
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","4/71","32/2914",0.00695091913482408,0.0302390350682858,0.0196003635995423,"MAPK1/MAPK3/GSK3B/SIRT1",4
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/71","32/2914",0.00695091913482408,0.0302390350682858,0.0196003635995423,"TP53/MAPK1/MAPK3/HDAC1",4
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","3/71","17/2914",0.00737715972076683,0.0318607767650509,0.0206515455188514,"HDAC1/SIRT1/TBP",3
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","16/71","347/2914",0.00767010144766073,0.0328876292288187,0.0213171316265921,"CTNNB1/STAT3/MAPK1/MAPK14/MAPK3/PRKACA/CHEK1/FGFR1/STAT1/CAV1/EGFR/ESR1/LCK/PPP2CA/ATF1/MEF2A",16
"R-HSA-373760","R-HSA-373760","L1CAM interactions","5/71","53/2914",0.00862207632270976,0.0367054106309644,0.023791744439357,"MAPK1/MAPK3/FGFR1/CSNK2A1/EGFR",5
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/71","18/2914",0.00869957193690717,0.0367726586836643,0.0238353333396411,"MAPK1/MAPK3/EGFR",3
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","7/71","99/2914",0.00945089558675684,0.0396671392232893,0.0257114802100798,"MAPK1/MAPK3/FGFR1/EGFR/ESR1/LCK/PPP2CA",7
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/71","56/2914",0.0108481562171913,0.0452132944436786,0.0293063918418051,"TP53/MAPK14/CHEK1/CSNK2A1/TBP",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","4/71","37/2914",0.0116513351724044,0.0475904427251823,0.0308472138469479,"CTNNB1/HDAC1/GSK3B/PPP2CA",4
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","3/71","20/2914",0.0117379112090634,0.0475904427251823,0.0308472138469479,"CREBBP/SP1/SREBF2",3
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","3/71","20/2914",0.0117379112090634,0.0475904427251823,0.0308472138469479,"MAPK3/HDAC1/TBP",3
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","3/71","20/2914",0.0117379112090634,0.0475904427251823,0.0308472138469479,"MAPK3/HDAC1/TBP",3
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","5/71","59/2914",0.0134401720748311,0.0541239361932386,0.0350820992280441,"TP53/MAPK1/MAPK3/HDAC1/CSNK2A1",5
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","4/71","39/2914",0.0139906617256563,0.0559626469026251,0.0362739163074239,"E2F1/MAX/SKP2/TFDP1",4
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","4/71","40/2914",0.015264559582378,0.0588885609599665,0.038170437782246,"E2F1/SKP2/PPP2CA/TFDP1",4
"R-HSA-69236","R-HSA-69236","G1 Phase","4/71","40/2914",0.015264559582378,0.0588885609599665,0.038170437782246,"E2F1/SKP2/PPP2CA/TFDP1",4
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","4/71","40/2914",0.015264559582378,0.0588885609599665,0.038170437782246,"E2F1/MAX/SKP2/TFDP1",4
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","4/71","40/2914",0.015264559582378,0.0588885609599665,0.038170437782246,"CREBBP/SMAD3/EP300/NOTCH1",4
"R-HSA-180024","R-HSA-180024","DARPP-32 events","3/71","22/2914",0.0153149781020047,0.0588885609599665,0.038170437782246,"PRKACA/PPP1CA/PPP2CA",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/71","22/2914",0.0153149781020047,0.0588885609599665,0.038170437782246,"CTNNB1/MAPK14/MEF2A",3
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","7/71","110/2914",0.0163396724793231,0.061870912149307,0.0401035407255311,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","5/71","62/2914",0.0164229432332648,0.061870912149307,0.0401035407255311,"TP53/PRKACA/HDAC1/IRF1/GATA3",5
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","4/71","41/2914",0.0166096408454516,0.061870912149307,0.0401035407255311,"STAT3/CHEK1/STAT1/LCK",4
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","4/71","41/2914",0.0166096408454516,0.061870912149307,0.0401035407255311,"STAT3/SYK/STAT1/LCK",4
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","4/71","41/2914",0.0166096408454516,0.061870912149307,0.0401035407255311,"MAPK1/MAPK3/FGFR1/PPP2CA",4
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","5/71","64/2914",0.018639844886445,0.0690021587100698,0.04472587821723,"CREBBP/HDAC1/EP300/NOTCH1/HIF1A",5
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","3/71","24/2914",0.0194423025153408,0.071089646007013,0.0460789475177919,"CREBBP/EP300/HIF1A",3
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","3/71","24/2914",0.0194423025153408,0.071089646007013,0.0460789475177919,"STAT3/FGFR1/STAT1",3
"R-HSA-69275","R-HSA-69275","G2/M Transition","5/71","66/2914",0.0210467033019692,0.0764867998047172,0.0495772792799916,"TP53/PRKACA/EP300/PPP2CA/MYBL2",5
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/71","45/2914",0.0227237601819798,0.0813878864103973,0.0527540697856161,"STAT3/MAPK1/MAPK3/RELA",4
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/71","10/2914",0.0232146655868583,0.0813878864103973,0.0527540697856161,"MAPK1/MAPK3",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/71","10/2914",0.0232146655868583,0.0813878864103973,0.0527540697856161,"MAPK1/MAPK3",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/71","10/2914",0.0232146655868583,0.0813878864103973,0.0527540697856161,"STAT3/STAT1",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/71","10/2914",0.0232146655868583,0.0813878864103973,0.0527540697856161,"STAT3/STAT1",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/71","10/2914",0.0232146655868583,0.0813878864103973,0.0527540697856161,"MAPK1/MAPK3",2
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","3/71","26/2914",0.0241259428742061,0.0840880815966483,0.0545042846096255,"CREBBP/HDAC1/NOTCH1",3
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","4/71","47/2914",0.0262340571666916,0.0898274145030555,0.0582244103190063,"CREBBP/SP1/EP300/SREBF2",4
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","4/71","47/2914",0.0262340571666916,0.0898274145030555,0.0582244103190063,"STAT3/EGFR/NR3C1/HIF1A",4
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","4/71","47/2914",0.0262340571666916,0.0898274145030555,0.0582244103190063,"STAT3/EGFR/NR3C1/HIF1A",4
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/71","27/2914",0.0266769335017463,0.0898274145030555,0.0582244103190063,"CREBBP/PAX6/EP300",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/71","27/2914",0.0266769335017463,0.0898274145030555,0.0582244103190063,"CREBBP/PAX6/EP300",3
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","3/71","27/2914",0.0266769335017463,0.0898274145030555,0.0582244103190063,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-69242","R-HSA-69242","S Phase","5/71","71/2914",0.0279308416217384,0.0899852339073039,0.0583267058353595,"E2F1/MAX/SKP2/GSK3B/TFDP1",5
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/71","11/2914",0.0279316581759249,0.0899852339073039,0.0583267058353595,"STAT3/STAT1",2
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","2/71","11/2914",0.0279316581759249,0.0899852339073039,0.0583267058353595,"CREBBP/EP300",2
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","2/71","11/2914",0.0279316581759249,0.0899852339073039,0.0583267058353595,"CASP1/TP53",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/71","11/2914",0.0279316581759249,0.0899852339073039,0.0583267058353595,"E2F1/TP53",2
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","2/71","11/2914",0.0279316581759249,0.0899852339073039,0.0583267058353595,"EGFR/ESR1",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/71","11/2914",0.0279316581759249,0.0899852339073039,0.0583267058353595,"STAT3/STAT1",2
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","2/71","11/2914",0.0279316581759249,0.0899852339073039,0.0583267058353595,"FOXO4/FOXO3",2
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","4/71","48/2914",0.0281051567537486,0.0900573840066353,0.0583734721484196,"CREBBP/SP1/EP300/SREBF2",4
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","3/71","28/2914",0.0293671108434015,0.092414908182751,0.0599015741841569,"AR/ESR1/NR3C1",3
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","3/71","28/2914",0.0293671108434015,0.092414908182751,0.0599015741841569,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","3/71","28/2914",0.0293671108434015,0.092414908182751,0.0599015741841569,"CREBBP/SP1/SREBF2",3
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","5/71","72/2914",0.0294611284475213,0.092414908182751,0.0599015741841569,"CREBBP/PRKACA/RELA/SYK/EP300",5
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","3/71","29/2914",0.0321959630338963,0.0990897027025189,0.0642280482017386,"E2F1/TP53/TFDP1",3
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/71","12/2914",0.0329970225221722,0.0990897027025189,0.0642280482017386,"MAPK1/MAPK3",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/71","12/2914",0.0329970225221722,0.0990897027025189,0.0642280482017386,"STAT3/STAT1",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/71","12/2914",0.0329970225221722,0.0990897027025189,0.0642280482017386,"CTNNB1/PAX6",2
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","2/71","12/2914",0.0329970225221722,0.0990897027025189,0.0642280482017386,"CASP1/RELA",2
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","2/71","12/2914",0.0329970225221722,0.0990897027025189,0.0642280482017386,"PRKACA/HDAC1",2
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","2/71","12/2914",0.0329970225221722,0.0990897027025189,0.0642280482017386,"PRKACA/HDAC1",2
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","2/71","12/2914",0.0329970225221722,0.0990897027025189,0.0642280482017386,"SYK/LCK",2
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","7/71","127/2914",0.0330853201976531,0.0990897027025189,0.0642280482017386,"MAPK1/MAPK14/MAPK3/RELA/PPP2CA/ATF1/MEF2A",7
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","4/71","51/2914",0.0341887975556318,0.0998849183488066,0.064743491759117,"CREBBP/HDAC1/EP300/NOTCH1",4
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","4/71","51/2914",0.0341887975556318,0.0998849183488066,0.064743491759117,"CREBBP/HDAC1/EP300/NOTCH1",4
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","4/71","51/2914",0.0341887975556318,0.0998849183488066,0.064743491759117,"CREBBP/HDAC1/EP300/NOTCH1",4
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","4/71","51/2914",0.0341887975556318,0.0998849183488066,0.064743491759117,"CREBBP/HDAC1/EP300/NOTCH1",4
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","4/71","51/2914",0.0341887975556318,0.0998849183488066,0.064743491759117,"CREBBP/HDAC1/EP300/NOTCH1",4
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","3/71","30/2914",0.0351627442393406,0.101241524476555,0.0656228178786575,"MAPK1/MAPK3/SYK",3
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/71","30/2914",0.0351627442393406,0.101241524476555,0.0656228178786575,"STAT3/TP53/CSNK2A1",3
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","3/71","30/2914",0.0351627442393406,0.101241524476555,0.0656228178786575,"CASP1/CREBBP/TP53",3
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","7/71","130/2914",0.0369253093388399,0.104006031070566,0.0674147181259232,"CTNNB1/PPP1CC/MAPK1/MAPK14/MAPK3/AR/PPP2CA",7
"R-HSA-391251","R-HSA-391251","Protein folding","3/71","31/2914",0.038266489982306,0.104006031070566,0.0674147181259232,"STAT3/TP53/CSNK2A1",3
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","3/71","31/2914",0.038266489982306,0.104006031070566,0.0674147181259232,"CTNNB1/GSK3B/PPP2CA",3
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","3/71","31/2914",0.038266489982306,0.104006031070566,0.0674147181259232,"STAT3/FGFR1/STAT1",3
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"CREBBP/EP300",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"MAPK1/MAPK3",2
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"GSK3B/PPP2CA",2
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"GSK3B/PPP2CA",2
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"GSK3B/PPP2CA",2
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"GSK3B/PPP2CA",2
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"GSK3B/PPP2CA",2
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"GSK3B/PPP2CA",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/71","13/2914",0.038391487979068,0.104006031070566,0.0674147181259232,"TP53/EP300",2
"R-HSA-68886","R-HSA-68886","M Phase","6/71","105/2914",0.040820360016616,0.110085676786892,0.0713554280833439,"PPP1CC/MAPK1/MAPK3/PRKACA/CSNK2A1/PPP2CA",6
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/71","32/2914",0.0415060317941144,0.110930919055122,0.0719032979392966,"MAPK1/MAPK3/FGFR1",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","3/71","32/2914",0.0415060317941144,0.110930919055122,0.0719032979392966,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","4/71","55/2914",0.0434105502056444,0.115503071082875,0.0748668793490201,"MAPK1/MAPK3/FGFR1/PPP2CA",4
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/71","14/2914",0.0440964931571983,0.116289866910134,0.0753768653409025,"CTNNB1/PAX6",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/71","14/2914",0.0440964931571983,0.116289866910134,0.0753768653409025,"CREBBP/EP300",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/71","33/2914",0.044880011218932,0.117317924063524,0.0760432323053927,"MAPK1/MAPK14/MAPK3",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/71","33/2914",0.044880011218932,0.117317924063524,0.0760432323053927,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","4/71","56/2914",0.0459153497432177,0.119500211558767,0.077457749279526,"PPP1CC/PRKACA/CSNK2A1/PPP2CA",4
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","2/71","15/2914",0.0500941635877027,0.1281378605076,0.0830565079588295,"AR/NR3C1",2
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","2/71","15/2914",0.0500941635877027,0.1281378605076,0.0830565079588295,"HDAC1/TBP",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/71","15/2914",0.0500941635877027,0.1281378605076,0.0830565079588295,"MAPK14/PPP2CA",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/71","15/2914",0.0500941635877027,0.1281378605076,0.0830565079588295,"CREBBP/TP53",2
"R-HSA-109582","R-HSA-109582","Hemostasis","12/71","298/2914",0.053442694564557,0.136118999831094,0.088229729667982,"TP53/MAPK1/MAPK14/MAPK3/PRKACA/HDAC1/SYK/CAV1/LCK/PPP2CA/IRF1/GATA3",12
"R-HSA-111885","R-HSA-111885","Opioid Signalling","4/71","59/2914",0.0539075847436359,0.13641269720399,0.0884200986822045,"MAPK1/PRKACA/PPP1CA/PPP2CA",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","9/71","202/2914",0.0540157660069489,0.13641269720399,0.0884200986822045,"DUSP2/MAPK1/MAPK3/PRKACA/DUSP5/FGFR1/EGFR/PPP2CA/FOXO3",9
"R-HSA-195721","R-HSA-195721","Signaling by WNT","8/71","172/2914",0.0552334867992134,0.138899401402241,0.0900319327351158,"CREBBP/CTNNB1/HDAC1/CSNK2A1/EP300/GSK3B/CAV1/PPP2CA",8
"R-HSA-622312","R-HSA-622312","Inflammasomes","2/71","16/2914",0.0563672900297003,0.141155062427317,0.091494009026537,"CASP1/RELA",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","3/71","37/2914",0.0596872189814845,0.14884344147684,0.0964774691310496,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/71","38/2914",0.0637072635999772,0.158206371273277,0.102546340970139,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","2/71","18/2914",0.0696742743376395,0.171594493823277,0.111224265689055,"PRKACA/GSK3B",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/71","18/2914",0.0696742743376395,0.171594493823277,0.111224265689055,"CSNK2A1/EP300",2
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","2/71","19/2914",0.0766768532979446,0.185017832249291,0.119925016664588,"CREBBP/BHLHE40",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","2/71","19/2914",0.0766768532979446,0.185017832249291,0.119925016664588,"CREBBP/EP300",2
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","2/71","19/2914",0.0766768532979446,0.185017832249291,0.119925016664588,"LCK/PPP2CA",2
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","2/71","19/2914",0.0766768532979446,0.185017832249291,0.119925016664588,"PRKACA/GSK3B",2
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","2/71","19/2914",0.0766768532979446,0.185017832249291,0.119925016664588,"HDAC1/TBP",2
"R-HSA-70171","R-HSA-70171","Glycolysis","2/71","20/2914",0.0838922913078202,0.199999222477843,0.129635666989348,"PRKACA/PPP2CA",2
"R-HSA-70326","R-HSA-70326","Glucose metabolism","2/71","20/2914",0.0838922913078202,0.199999222477843,0.129635666989348,"PRKACA/PPP2CA",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","2/71","20/2914",0.0838922913078202,0.199999222477843,0.129635666989348,"HDAC1/EP300",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/71","43/2914",0.0856042274141603,0.203267408521273,0.131754042612694,"MAPK1/MAPK3/SYK",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","11/71","289/2914",0.087673950381604,0.206576304063602,0.133898805353836,"CREBBP/PPP1CC/PRKACA/PDK1/SP1/CSNK2A1/EP300/PPP1CA/CAV1/PPP2CA/SREBF2",11
"R-HSA-168249","R-HSA-168249","Innate Immune System","15/71","428/2914",0.0876909478659252,0.206576304063602,0.133898805353836,"CASP1/CREBBP/CTNNB1/MAPK1/MAPK14/MAPK3/PRKACA/RELA/SYK/EP300/LCK/PPP2CA/PRKDC/ATF1/MEF2A",15
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","2/71","21/2914",0.0913064012186698,0.214246516245383,0.138870490042486,"CTNNB1/CASP3",2
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","3/71","45/2914",0.0951539595612455,0.222399058425499,0.144154811801763,"STAT3/FGFR1/STAT1",3
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","4/71","72/2914",0.0965949055420981,0.224885014465197,0.145766160912623,"FGFR1/EGFR/ESR1/LCK",4
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/71","22/2914",0.0989055435303365,0.228479472651475,0.148096019892425,"MAPK1/MAPK3",2
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","2/71","22/2914",0.0989055435303365,0.228479472651475,0.148096019892425,"PRKACA/HDAC1",2
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","3/71","47/2914",0.105122917697459,0.24190447470149,0.156797849197186,"MAPK1/MAPK3/PRKACA",3
"R-HSA-201451","R-HSA-201451","Signaling by BMP","2/71","23/2914",0.106676608741565,0.243598692758517,0.157896008905644,"SMAD4/SMAD7",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/71","23/2914",0.106676608741565,0.243598692758517,0.157896008905644,"STAT3/STAT1",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","3/71","48/2914",0.110257435093707,0.250814623342936,0.162573236960186,"CASP1/MAPK14/RELA",3
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","2/71","24/2914",0.114607000216677,0.25678861702684,0.166445465292918,"SYK/LCK",2
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","2/71","24/2914",0.114607000216677,0.25678861702684,0.166445465292918,"SYK/LCK",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/71","24/2914",0.114607000216677,0.25678861702684,0.166445465292918,"TP53/CHEK1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/71","24/2914",0.114607000216677,0.25678861702684,0.166445465292918,"STAT3/STAT1",2
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","3/71","49/2914",0.115488071827115,0.257793598535433,0.167096875066238,"MAPK1/MAPK3/PRKACA",3
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","7/71","171/2914",0.119784836853497,0.266387174495091,0.172667066477743,"DUSP2/MAPK1/MAPK3/DUSP5/FGFR1/EGFR/PPP2CA",7
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","3/71","50/2914",0.120811858216212,0.267672369876811,0.17350010551888,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/71","25/2914",0.122684617554287,0.268823647288069,0.174246341495446,"MAPK1/MAPK3",2
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","2/71","25/2914",0.122684617554287,0.268823647288069,0.174246341495446,"CTNNB1/CAV1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/71","25/2914",0.122684617554287,0.268823647288069,0.174246341495446,"MAPK1/MAPK3",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/71","26/2914",0.130897840444293,0.284453700197652,0.184377442551286,"MAPK1/PRKACA",2
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","2/71","26/2914",0.130897840444293,0.284453700197652,0.184377442551286,"CTNNB1/CASP3",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/71","52/2914",0.131726881299584,0.284453700197652,0.184377442551286,"MAPK1/MAPK3/FGFR1",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/71","52/2914",0.131726881299584,0.284453700197652,0.184377442551286,"MAPK1/MAPK3/FGFR1",3
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","7/71","177/2914",0.136702879331641,0.294133271052917,0.190651555062558,"DUSP2/MAPK1/MAPK3/DUSP5/FGFR1/EGFR/PPP2CA",7
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","4/71","82/2914",0.1375858373768,0.294968198117169,0.191192738800779,"CASP1/SMAD3/STAT3/RELA",4
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/71","27/2914",0.139235512999697,0.297435002680357,0.192791674291224,"TP53/ESR1",2
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","2/71","28/2914",0.147686928550182,0.313243449878677,0.203038407109633,"SYK/LCK",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/71","28/2914",0.147686928550182,0.313243449878677,0.203038407109633,"CREBBP/EP300",2
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","4/71","85/2914",0.151086073546983,0.31931666607802,0.20697494957724,"CTNNB1/MAPK14/PRKACA/CAV1",4
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","2/71","29/2914",0.156241814884721,0.324460354255379,0.210308989776977,"PPP1CC/PPP2CA",2
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2/71","29/2914",0.156241814884721,0.324460354255379,0.210308989776977,"PPP1CC/PPP2CA",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/71","29/2914",0.156241814884721,0.324460354255379,0.210308989776977,"STAT3/STAT1",2
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","2/71","29/2914",0.156241814884721,0.324460354255379,0.210308989776977,"TP53/PPP2CA",2
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","2/71","29/2914",0.156241814884721,0.324460354255379,0.210308989776977,"TP53/PPP2CA",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","4/71","87/2914",0.160362661372277,0.331861618673185,0.215106347674071,"MAPK1/MAPK3/RELA/SYK",4
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","7/71","188/2914",0.170623411741509,0.351873887190102,0.228077916988286,"DUSP2/MAPK1/MAPK3/DUSP5/FGFR1/EGFR/PPP2CA",7
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/71","31/2914",0.173622997858303,0.356825195598444,0.231287260304891,"CTNNB1/HDAC1",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/71","32/2914",0.182430795595916,0.372358747175226,0.241355811044345,"STAT3/STAT1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/71","32/2914",0.182430795595916,0.372358747175226,0.241355811044345,"MAPK1/MAPK3",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","4/71","92/2914",0.184441237914257,0.375177398624223,0.24318280695,"CTNNB1/MAPK14/PRKACA/CAV1",4
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/71","62/2914",0.190862659388503,0.386501029459542,0.250522567664521,"MAPK1/MAPK3/SYK",3
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/71","33/2914",0.19130503974927,0.386501029459542,0.250522567664521,"CASP1/MAPK14",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"MAPK1/PRKACA",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"MAPK1/PRKACA",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"MAPK3/STAT1",2
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"PPP1CC/PPP2CA",2
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"CREBBP/EP300",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"MAPK1/MAPK3",2
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"PRKACA/FOXO3",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/71","34/2914",0.200237423909009,0.393866351979436,0.255296628711503,"TP53/CHEK1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/71","35/2914",0.209219996338331,0.408836451861133,0.264999960849586,"MAPK3/STAT1",2
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","2/71","35/2914",0.209219996338331,0.408836451861133,0.264999960849586,"PRKACA/GSK3B",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","3/71","66/2914",0.216195952803422,0.416823877204871,0.270177257036715,"CREBBP/RELA/EP300",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/71","10/2914",0.218902472424706,0.416823877204871,0.270177257036715,"MAPK3",1
"R-HSA-164938","R-HSA-164938","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","1/71","10/2914",0.218902472424706,0.416823877204871,0.270177257036715,"LCK",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/71","10/2914",0.218902472424706,0.416823877204871,0.270177257036715,"SYK",1
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","1/71","10/2914",0.218902472424706,0.416823877204871,0.270177257036715,"RELA",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/71","10/2914",0.218902472424706,0.416823877204871,0.270177257036715,"RELA",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/71","10/2914",0.218902472424706,0.416823877204871,0.270177257036715,"TP53",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/71","10/2914",0.218902472424706,0.416823877204871,0.270177257036715,"CSNK2A1",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","2/71","37/2914",0.227305601117766,0.42596917145451,0.27610506168104,"CREBBP/EP300",2
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/71","38/2914",0.236394397646532,0.42596917145451,0.27610506168104,"CREBBP/MAPK14",2
"R-HSA-163615","R-HSA-163615","PKA activation","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"PRKACA",1
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"PRKDC",1
"R-HSA-1839122","R-HSA-1839122","Signaling by activated point mutants of FGFR1","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"FGFR1",1
"R-HSA-190373","R-HSA-190373","FGFR1c ligand binding and activation","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"FGFR1",1
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"RELA",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"PAX6",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"LCK",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"EP300",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"STAT3",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"TP53",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"ATF4",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"CHEK1",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"CHEK1",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"CHEK1",1
"R-HSA-73772","R-HSA-73772","RNA Polymerase I Promoter Escape","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"TBP",1
"R-HSA-73863","R-HSA-73863","RNA Polymerase I Transcription Termination","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"TBP",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"CHEK1",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/71","11/2914",0.237999553849583,0.42596917145451,0.27610506168104,"GSK3B",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"CSNK2A1",1
"R-HSA-202427","R-HSA-202427","Phosphorylation of CD3 and TCR zeta chains","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"LCK",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"RUNX2",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"NOTCH1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"LCK",1
"R-HSA-389948","R-HSA-389948","PD-1 signaling","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"LCK",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"PRKACA",1
"R-HSA-5362517","R-HSA-5362517","Signaling by Retinoic Acid","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"PDK1",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"PRKACA",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/71","12/2914",0.256636147606621,0.443348243401584,0.287369843391701,"HDAC1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","2/71","41/2914",0.263765840348938,0.448281417567238,0.290567432439379,"PRKACA/HDAC1",2
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"CTNNB1/PAX6",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"MAPK14/PPP2CA",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"MAPK1/MAPK3",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"MAPK1/MAPK3",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"MAPK1/MAPK3",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"PPP1CC/PPP2CA",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"STAT1/IRF1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/71","42/2914",0.27290445463246,0.448281417567238,0.290567432439379,"MAPK1/MAPK3",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","4/71","109/2914",0.27363914255169,0.448281417567238,0.290567432439379,"CREBBP/HDAC1/RELA/EP300",4
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","4/71","109/2914",0.27363914255169,0.448281417567238,0.290567432439379,"CREBBP/HDAC1/RELA/EP300",4
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"PRKACA",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"MAPK14",1
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"EGFR",1
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"RELA",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"GSK3B",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"NOTCH1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"EP300",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/71","13/2914",0.274823202575584,0.448281417567238,0.290567432439379,"EGFR",1
"R-HSA-422475","R-HSA-422475","Axon guidance","8/71","254/2914",0.275286910787935,0.448281417567238,0.290567432439379,"MAPK1/MAPK14/MAPK3/PRKACA/FGFR1/CSNK2A1/GSK3B/EGFR",8
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","2/71","43/2914",0.282041051082134,0.456472672647802,0.295876847159561,"RELA/LCK",2
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","3/71","76/2914",0.282121980505085,0.456472672647802,0.295876847159561,"HDAC1/RELA/CASP3",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","3/71","77/2914",0.288845361139524,0.456472672647802,0.295876847159561,"MAPK1/MAPK3/PRKACA",3
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/71","44/2914",0.291170373533539,0.456472672647802,0.295876847159561,"EGFR/ESR1",2
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","2/71","44/2914",0.291170373533539,0.456472672647802,0.295876847159561,"PRKACA/PPP2CA",2
"R-HSA-1428517","R-HSA-1428517","The citric acid (TCA) cycle and respiratory electron transport","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"PDK1",1
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"EGFR",1
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"ATF4",1
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"EGFR",1
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"EGFR",1
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"EGFR",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"STAT1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"STAT3",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"PPP2CA",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/71","14/2914",0.292571410992383,0.456472672647802,0.295876847159561,"PPP2CA",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","2/71","45/2914",0.300287416043878,0.466401928710972,0.302312800842329,"PRKACA/SYK",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/71","114/2914",0.301316162406427,0.466401928710972,0.302312800842329,"PPP1CC/TP53/CHEK1/PPP2CA",4
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/71","80/2914",0.309089242261091,0.466401928710972,0.302312800842329,"CREBBP/MAPK14/PRKACA",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/71","46/2914",0.309387414113388,0.466401928710972,0.302312800842329,"MAPK1/MAPK3",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/71","46/2914",0.309387414113388,0.466401928710972,0.302312800842329,"TP53/CHEK1",2
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"LCK",1
"R-HSA-190242","R-HSA-190242","FGFR1 ligand binding and activation","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"FGFR1",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"CASP3",1
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"SYK",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"PRKACA",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"FOXO3",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"FOXO3",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/71","15/2914",0.309891214378431,0.466401928710972,0.302312800842329,"CTNNB1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","3/71","81/2914",0.315854149198202,0.470455348704512,0.304940150078693,"TP53/CHEK1/PRKDC",3
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","5/71","153/2914",0.315868492368974,0.470455348704512,0.304940150078693,"MAPK1/MAPK14/MAPK3/SYK/LCK",5
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/71","47/2914",0.318465836176318,0.470455348704512,0.304940150078693,"PPP1CC/PPP2CA",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","2/71","47/2914",0.318465836176318,0.470455348704512,0.304940150078693,"STAT1/IRF1",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","7/71","228/2914",0.318583621797049,0.470455348704512,0.304940150078693,"CTNNB1/PPP1CC/MAPK1/MAPK14/MAPK3/AR/PPP2CA",7
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"EGFR",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"CHEK1",1
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"RELA",1
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"EGFR",1
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"EGFR",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"HDAC1",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"TP53",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"CSNK2A1",1
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"EGFR",1
"R-HSA-5654219","R-HSA-5654219","Phospholipase C-mediated cascade: FGFR1","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"FGFR1",1
"R-HSA-73933","R-HSA-73933","Resolution of Abasic Sites (AP sites)","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"TDG",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"TP53",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/71","16/2914",0.326792809335013,0.470455348704512,0.304940150078693,"EP300",1
"R-HSA-73894","R-HSA-73894","DNA Repair","5/71","157/2914",0.335499328509674,0.475810575140907,0.308411305327999,"TP53/CHEK1/EP300/PRKDC/TDG",5
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/71","49/2914",0.336540941461343,0.475810575140907,0.308411305327999,"STAT3/STAT1",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/71","49/2914",0.336540941461343,0.475810575140907,0.308411305327999,"MAPK1/MAPK3",2
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"PRKACA",1
"R-HSA-164952","R-HSA-164952","The role of Nef in HIV-1 replication and disease pathogenesis","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"LCK",1
"R-HSA-167161","R-HSA-167161","HIV Transcription Initiation","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"TBP",1
"R-HSA-167162","R-HSA-167162","RNA Polymerase II HIV Promoter Escape","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"TBP",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"EGFR",1
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"SYK",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"MAPK14",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"RELA",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"SKP2",1
"R-HSA-73776","R-HSA-73776","RNA Polymerase II Promoter Escape","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"TBP",1
"R-HSA-73779","R-HSA-73779","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"TBP",1
"R-HSA-75953","R-HSA-75953","RNA Polymerase II Transcription Initiation","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"TBP",1
"R-HSA-76042","R-HSA-76042","RNA Polymerase II Transcription Initiation And Promoter Clearance","1/71","17/2914",0.343286153205688,0.475810575140907,0.308411305327999,"TBP",1
"R-HSA-69306","R-HSA-69306","DNA Replication","2/71","51/2914",0.354480830967538,0.489052257538548,0.316994310343778,"E2F1/SKP2",2
"R-HSA-8951664","R-HSA-8951664","Neddylation","2/71","51/2914",0.354480830967538,0.489052257538548,0.316994310343778,"SKP2/HIF1A",2
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/71","18/2914",0.35938096960969,0.490139720566077,0.317699183058548,"HIF1A",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/71","18/2914",0.35938096960969,0.490139720566077,0.317699183058548,"LCK",1
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","1/71","18/2914",0.35938096960969,0.490139720566077,0.317699183058548,"CASP3",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/71","18/2914",0.35938096960969,0.490139720566077,0.317699183058548,"PRKACA",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/71","18/2914",0.35938096960969,0.490139720566077,0.317699183058548,"PPP2CA",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","3/71","88/2914",0.363225424569708,0.494251947588004,0.320364649884842,"MAPK1/MAPK3/PRKACA",3
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","2/71","53/2914",0.372256828730082,0.503494831743564,0.32635571043781,"LCK/PPP2CA",2
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","2/71","53/2914",0.372256828730082,0.503494831743564,0.32635571043781,"RELA/SYK",2
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","1/71","19/2914",0.375086753849232,0.503494831743564,0.32635571043781,"RELA",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/71","19/2914",0.375086753849232,0.503494831743564,0.32635571043781,"CTNNB1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/71","19/2914",0.375086753849232,0.503494831743564,0.32635571043781,"CSNK2A1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/71","19/2914",0.375086753849232,0.503494831743564,0.32635571043781,"EP300",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/71","55/2914",0.389843254573588,0.513655664025024,0.332941767391706,"PRKACA/PPP2CA",2
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","2/71","55/2914",0.389843254573588,0.513655664025024,0.332941767391706,"PRKACA/GSK3B",2
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/71","20/2914",0.390412778193517,0.513655664025024,0.332941767391706,"MAPK14",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/71","20/2914",0.390412778193517,0.513655664025024,0.332941767391706,"MAPK1",1
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","1/71","20/2914",0.390412778193517,0.513655664025024,0.332941767391706,"RELA",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/71","20/2914",0.390412778193517,0.513655664025024,0.332941767391706,"PRKACA",1
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","1/71","20/2914",0.390412778193517,0.513655664025024,0.332941767391706,"RELA",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/71","20/2914",0.390412778193517,0.513655664025024,0.332941767391706,"EGFR",1
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","1/71","20/2914",0.390412778193517,0.513655664025024,0.332941767391706,"SYK",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","2/71","56/2914",0.398558118926818,0.523217266256352,0.339139414899472,"PPP1CC/PPP2CA",2
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/71","21/2914",0.405368097042259,0.524076758865914,0.339696521553851,"NOTCH1",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/71","21/2914",0.405368097042259,0.524076758865914,0.339696521553851,"LCK",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/71","21/2914",0.405368097042259,0.524076758865914,0.339696521553851,"MAPK14",1
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","1/71","21/2914",0.405368097042259,0.524076758865914,0.339696521553851,"FGFR1",1
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","1/71","21/2914",0.405368097042259,0.524076758865914,0.339696521553851,"FGFR1",1
"R-HSA-73884","R-HSA-73884","Base Excision Repair","1/71","21/2914",0.405368097042259,0.524076758865914,0.339696521553851,"TDG",1
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","1/71","21/2914",0.405368097042259,0.524076758865914,0.339696521553851,"RELA",1
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"EGFR",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"STAT3",1
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"EGFR",1
"R-HSA-167172","R-HSA-167172","Transcription of the HIV genome","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"TBP",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"SKP2",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"PRKACA",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"TP53",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"PRKDC",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/71","22/2914",0.419961551971399,0.530290434268969,0.343724106988187,"EP300",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","3/71","97/2914",0.423398233753725,0.533499677203425,0.345804276816773,"MAPK3/STAT1/IRF1",3
"R-HSA-202403","R-HSA-202403","TCR signaling","2/71","59/2914",0.424358371590496,0.533581412379611,0.345857255993142,"RELA/LCK",2
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","2/71","60/2914",0.432835964104423,0.538013012248531,0.348729734184406,"PPP1CC/PPP2CA",2
"R-HSA-392518","R-HSA-392518","Signal amplification","1/71","23/2914",0.434201776663663,0.538013012248531,0.348729734184406,"MAPK14",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/71","23/2914",0.434201776663663,0.538013012248531,0.348729734184406,"HDAC1",1
"R-HSA-5357769","R-HSA-5357769","Caspase activation via extrinsic apoptotic signalling pathway","1/71","23/2914",0.434201776663663,0.538013012248531,0.348729734184406,"CASP3",1
"R-HSA-5654693","R-HSA-5654693","FRS-mediated FGFR1 signaling","1/71","23/2914",0.434201776663663,0.538013012248531,0.348729734184406,"FGFR1",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/71","23/2914",0.434201776663663,0.538013012248531,0.348729734184406,"CHEK1",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/71","23/2914",0.434201776663663,0.538013012248531,0.348729734184406,"E2F1",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","2/71","61/2914",0.441248811425917,0.545610563505906,0.353654321452963,"PPP1CC/PPP2CA",2
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/71","24/2914",0.448097201726576,0.547266254567703,0.354727508700719,"RELA",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/71","24/2914",0.448097201726576,0.547266254567703,0.354727508700719,"TP53",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/71","24/2914",0.448097201726576,0.547266254567703,0.354727508700719,"AR",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/71","24/2914",0.448097201726576,0.547266254567703,0.354727508700719,"CHEK1",1
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","1/71","24/2914",0.448097201726576,0.547266254567703,0.354727508700719,"EGFR",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/71","24/2914",0.448097201726576,0.547266254567703,0.354727508700719,"STAT1",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","2/71","62/2914",0.449595016493831,0.54797265813972,0.355185385971878,"TP53/CHEK1",2
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","2/71","63/2914",0.457872810044795,0.55361571710795,0.358843108757714,"RELA/SYK",2
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/71","25/2914",0.461656059400421,0.55361571710795,0.358843108757714,"PRKACA",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/71","25/2914",0.461656059400421,0.55361571710795,0.358843108757714,"PRKACA",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/71","25/2914",0.461656059400421,0.55361571710795,0.358843108757714,"SYK",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/71","25/2914",0.461656059400421,0.55361571710795,0.358843108757714,"PRKACA",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/71","25/2914",0.461656059400421,0.55361571710795,0.358843108757714,"PRKACA",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/71","25/2914",0.461656059400421,0.55361571710795,0.358843108757714,"CSNK2A1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/71","25/2914",0.461656059400421,0.55361571710795,0.358843108757714,"SYK",1
"R-HSA-182971","R-HSA-182971","EGFR downregulation","1/71","26/2914",0.474886388158666,0.564323768133271,0.36578386242478,"EGFR",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/71","26/2914",0.474886388158666,0.564323768133271,0.36578386242478,"PRKACA",1
"R-HSA-674695","R-HSA-674695","RNA Polymerase II Pre-transcription Events","1/71","26/2914",0.474886388158666,0.564323768133271,0.36578386242478,"TBP",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/71","26/2914",0.474886388158666,0.564323768133271,0.36578386242478,"PRKACA",1
"R-HSA-112316","R-HSA-112316","Neuronal System","3/71","105/2914",0.475319683897486,0.564323768133271,0.36578386242478,"MAPK1/MAPK3/PRKACA",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","3/71","106/2914",0.481670707745589,0.566718203066535,0.367335889306638,"HDAC1/RELA/CASP3",3
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"ESR1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"NOTCH1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"PRKACA",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"PRKACA",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"RELA",1
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"SMAD7",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"PRKDC",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"PRKDC",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"GATA3",1
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","1/71","27/2914",0.487796037203242,0.566718203066535,0.367335889306638,"SYK",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/71","28/2914",0.500392670857059,0.575741374190748,0.373184536079132,"SKP2",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/71","28/2914",0.500392670857059,0.575741374190748,0.373184536079132,"PRKACA",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/71","28/2914",0.500392670857059,0.575741374190748,0.373184536079132,"PRKACA",1
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","1/71","28/2914",0.500392670857059,0.575741374190748,0.373184536079132,"FGFR1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/71","28/2914",0.500392670857059,0.575741374190748,0.373184536079132,"EP300",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","2/71","69/2914",0.506018740386388,0.581092811696122,0.37665323541589,"CAV1/LCK",2
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/71","29/2914",0.512683772856071,0.584243840577855,0.378695672010019,"EP300",1
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","1/71","29/2914",0.512683772856071,0.584243840577855,0.378695672010019,"SYK",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/71","29/2914",0.512683772856071,0.584243840577855,0.378695672010019,"ATF4",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/71","29/2914",0.512683772856071,0.584243840577855,0.378695672010019,"PPP2CA",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/71","30/2914",0.524676650543149,0.595632921378508,0.386077856139019,"CSNK2A1",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/71","30/2914",0.524676650543149,0.595632921378508,0.386077856139019,"PRKACA",1
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/71","31/2914",0.536378438965977,0.604312948249003,0.391704083375811,"PRKACA",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/71","31/2914",0.536378438965977,0.604312948249003,0.391704083375811,"RELA",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/71","31/2914",0.536378438965977,0.604312948249003,0.391704083375811,"LCK",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/71","31/2914",0.536378438965977,0.604312948249003,0.391704083375811,"MAPK14",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/71","32/2914",0.54779610488114,0.613696388175112,0.397786249488284,"CREBBP",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/71","32/2914",0.54779610488114,0.613696388175112,0.397786249488284,"EP300",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/71","32/2914",0.54779610488114,0.613696388175112,0.397786249488284,"PRKACA",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/71","33/2914",0.558936450666511,0.621503963800822,0.402846970531441,"CHEK1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/71","33/2914",0.558936450666511,0.621503963800822,0.402846970531441,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/71","33/2914",0.558936450666511,0.621503963800822,0.402846970531441,"SKP2",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/71","33/2914",0.558936450666511,0.621503963800822,0.402846970531441,"SYK",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/71","34/2914",0.569806118144011,0.632410514737115,0.409916388040482,"TP53",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/71","35/2914",0.580411592314766,0.638238577526939,0.413694026761545,"MAPK14",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/71","35/2914",0.580411592314766,0.638238577526939,0.413694026761545,"CTNNB1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/71","35/2914",0.580411592314766,0.638238577526939,0.413694026761545,"PRKACA",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/71","35/2914",0.580411592314766,0.638238577526939,0.413694026761545,"TP53",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/71","35/2914",0.580411592314766,0.638238577526939,0.413694026761545,"TP53",1
"R-HSA-162906","R-HSA-162906","HIV Infection","2/71","80/2914",0.586940637330265,0.644229502484047,0.417577229621415,"LCK/TBP",2
"R-HSA-5663205","R-HSA-5663205","Infectious disease","3/71","126/2914",0.600321994783805,0.657081949571063,0.425907939760827,"CTNNB1/LCK/TBP",3
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/71","37/2914",0.600855138450049,0.657081949571063,0.425907939760827,"PRKACA",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/71","38/2914",0.610705428742037,0.664197875055208,0.430520346423987,"RELA",1
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/71","38/2914",0.610705428742037,0.664197875055208,0.430520346423987,"TDG",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/71","38/2914",0.610705428742037,0.664197875055208,0.430520346423987,"GSK3B",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","1/71","39/2914",0.62031596927031,0.672196941245645,0.435705187985079,"RELA",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/71","39/2914",0.62031596927031,0.672196941245645,0.435705187985079,"EP300",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/71","40/2914",0.6296925140292,0.678655946403984,0.439891791469908,"SKP2",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/71","40/2914",0.6296925140292,0.678655946403984,0.439891791469908,"CTNNB1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/71","40/2914",0.6296925140292,0.678655946403984,0.439891791469908,"SKP2",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/71","42/2914",0.647765954681908,0.693121201059995,0.449267892598054,"FGFR1",1
"R-HSA-162599","R-HSA-162599","Late Phase of HIV Life Cycle","1/71","42/2914",0.647765954681908,0.693121201059995,0.449267892598054,"TBP",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/71","42/2914",0.647765954681908,0.693121201059995,0.449267892598054,"PRKACA",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/71","42/2914",0.647765954681908,0.693121201059995,0.449267892598054,"STAT3",1
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/71","44/2914",0.664969116457446,0.707717131086853,0.458728694999779,"EGFR",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/71","44/2914",0.664969116457446,0.707717131086853,0.458728694999779,"EGFR",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/71","44/2914",0.664969116457446,0.707717131086853,0.458728694999779,"SKP2",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/71","45/2914",0.67325733692139,0.715260914091174,0.463618430716109,"PRKACA",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/71","46/2914",0.681343335206013,0.722563394631287,0.468351758794918,"FGFR1",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/71","48/2914",0.696928010555978,0.737778142613433,0.478213667147881,"CHEK1",1
"R-HSA-162909","R-HSA-162909","Host Interactions of HIV factors","1/71","49/2914",0.70443607449545,0.744404078722142,0.482508472078817,"LCK",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/71","50/2914",0.711760695336924,0.750813052072224,0.486662645903402,"FGFR1",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/71","51/2914",0.718906292624312,0.755675750271763,0.489814553779119,"FGFR1",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/71","51/2914",0.718906292624312,0.755675750271763,0.489814553779119,"FGFR1",1
"R-HSA-162587","R-HSA-162587","HIV Life Cycle","1/71","53/2914",0.732677572320058,0.764756275136172,0.49570037614796,"TBP",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/71","53/2914",0.732677572320058,0.764756275136172,0.49570037614796,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/71","53/2914",0.732677572320058,0.764756275136172,0.49570037614796,"PRKACA",1
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","1/71","53/2914",0.732677572320058,0.764756275136172,0.49570037614796,"EGFR",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","6/71","296/2914",0.742988165239326,0.774162493850766,0.501797307035025,"PRKACA/RELA/SKP2/SYK/LCK/PPP2CA",6
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/71","55/2914",0.745783214371936,0.77571866625772,0.502805988196014,"EP300",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","2/71","109/2914",0.752828759363451,0.781682823311179,0.506671840613216,"MAPK14/PPP2CA",2
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/71","57/2914",0.758254954869952,0.784583251914047,0.508551842904372,"CTNNB1",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/71","57/2914",0.758254954869952,0.784583251914047,0.508551842904372,"RELA",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/71","59/2914",0.770123037694226,0.795482375157294,0.515616445924986,"CHEK1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/71","165/2914",0.776898179969467,0.801092240937374,0.519252653521753,"MAPK1/MAPK3/EGFR",3
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/71","61/2914",0.781416283693889,0.802972594968204,0.520471463004823,"CASP3",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/71","61/2914",0.781416283693889,0.802972594968204,0.520471463004823,"CSNK2A1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/71","62/2914",0.786855976598808,0.806349969386252,0.522660612442166,"STAT3",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","4/71","217/2914",0.787408862722817,0.806349969386252,0.522660612442166,"MAPK1/PRKACA/PPP1CA/PPP2CA",4
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/71","63/2914",0.792162156704518,0.809826149907192,0.524913806103743,"CHEK1",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/71","64/2914",0.797338055292375,0.813721713962766,0.527438836143298,"PRKACA",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","1/71","66/2914",0.807311549366852,0.822491766534434,0.533123416316032,"EGFR",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/71","125/2914",0.817596654972099,0.831548816319746,0.538994022588037,"MAPK1/MAPK14",2
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","1/71","70/2914",0.82582899740357,0.838490770787951,0.543493664569371,"CASP3",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/71","76/2914",0.850363069109406,0.86193263467552,0.558688231942628,"CTNNB1",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/71","88/2914",0.889658181075203,0.900231368286623,0.583512737833258,"SKP2",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/71","115/2914",0.944668024676972,0.954274818148264,0.618542667362085,"SKP2",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/71","121/2914",0.952579696947373,0.960638746836945,0.622667644099539,"PRKACA",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","6/71","436/2914",0.966121196317446,0.97264904223851,0.630452487639585,"MAPK1/MAPK3/PRKACA/PPP1CA/EGFR/PPP2CA",6
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","1/71","144/2914",0.973834572627867,0.97876122307961,0.634414286241994,"EGFR",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","1/71","157/2914",0.981344553517111,0.984401212163901,0.638070019187834,"CASP3",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","1/71","160/2914",0.98274953227772,0.984401212163901,0.638070019187834,"EGFR",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","6/71","486/2914",0.98594746351328,0.98594746351328,0.639072269709243,"MAPK1/MAPK3/PRKACA/PPP1CA/EGFR/PPP2CA",6
